Peripheral Transgene Expression of Plasma Gelsolin Reduces Amyloid in Transgenic Mouse Models of Alzheimer's Disease
Open Access
- 1 September 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (9), 1623-1629
- https://doi.org/10.1038/sj.mt.6300253
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trialNeurology, 2005
- Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunizationNeurology, 2003
- Novel Therapeutic Approach for the Treatment of Alzheimer's Disease by Peripheral Administration of Agents with an Affinity to β-AmyloidJournal of Neuroscience, 2003
- Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's diseaseNature, 2000
- Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer diseaseNature Medicine, 2000
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999
- Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic miceNature Medicine, 1997
- In the beginning ...Nature, 1991
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990
- The Deposition of Amyloid Proteins in the Aging Mammalian Brain: Implications for Alzheimer's DiseaseAnnals of Medicine, 1989